TNC.NYSETennant CO

10-Q: Tennant Company Reports Q2 2026 Results: Revenue Up, Profits Down

Sentiment:

Quarterly Report


Tennant Company's Q2 2026 report shows a 1.7% revenue increase to $324.0 million, but net income fell to $7.6 million from $20.2 million year-over-year, impacted by higher costs and operational challenges.

Delay expectedTargeted productivity gains and cost efficiencies from the North America ERP implementation have taken longer to realize than expected.The timing and pace of backlog reduction remain subject to supplier performance, long lead-time components, and changes in customer demand.
Worse than expectedNet income for Q2 2026 was $7.6 million, a significant decrease from $20.2 million in Q2 2025.Diluted EPS fell to $0.44 from $1.08 year-over-year.Gross profit margin declined to 39.5% from 42.1% due to ERP recovery costs, supply constraints, and elevated freight/material costs.Operating income decreased to $15.9 million from $30.6 million year-over-year.Net cash used in operating activities for the first six months of 2026 was $26.2 million, a reversal from positive cash flow in the prior year.

Summary

  • Tennant Company reported net sales of $324.0 million for the second quarter of 2026, a 1.7% increase compared to $318.6 million in the same period of 2025.
  • Net income for the quarter decreased significantly to $7.6 million ($0.44 per diluted share) from $20.2 million ($1.08 per diluted share) in Q2 2025.
  • Gross profit margin declined to 39.5% from 42.1% year-over-year, attributed to ERP recovery costs, supply constraints, and elevated freight/material costs.
  • Selling and administrative expenses increased by $5.8 million to $99.5 million, representing 30.7% of net sales, up from 29.4% in the prior year.
  • Research and development expenses increased to $12.5 million (3.9% of net sales) from $9.8 million (3.1% of net sales) due to continued investment in innovation.
  • Net cash used in operating activities for the first six months of 2026 was $26.2 million, a reversal from $22.1 million provided in the same period of 2025, largely due to lower operating performance and increased working capital needs.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to declining net income, reduced gross profit margins, and increased operating expenses, despite slight revenue growth.

Positives

  • Consolidated net sales increased by 1.7% to $324.0 million in Q2 2026 compared to Q2 2025.
  • Acquisitions contributed 0.6% to net sales growth.
  • Favorable foreign currency exchange rates provided a 1.6% boost to Q2 2026 net sales.
  • Americas net sales increased by 2.4% to $218.7 million in Q2 2026.
  • EMEA net sales increased by 2.1% to $86.5 million in Q2 2026, driven by acquisitions and favorable foreign currency.

Negatives

  • Net income for Q2 2026 decreased to $7.6 million from $20.2 million in Q2 2025.
  • Diluted earnings per share decreased to $0.44 in Q2 2026 from $1.08 in Q2 2025.
  • Gross profit margin decreased by 260 basis points to 39.5% in Q2 2026 compared to Q2 2025.
  • Selling and administrative expenses increased by $5.8 million to $99.5 million in Q2 2026.
  • Net cash used in operating activities for the first six months of 2026 was $26.2 million, compared to net cash provided by operating activities of $22.1 million in the prior year.
  • APAC net sales decreased by 7.8% to $18.8 million in Q2 2026.
  • The company incurred $0.5 million in equity method losses from its investment in Brain Corp.

Risks

  • Macroeconomic, geopolitical, and regulatory conditions, including inflationary pressures, interest rate volatility, foreign currency fluctuations, and supply chain disruptions, continue to influence the operating environment.
  • Uncertainty regarding tariff levels, duration, refund eligibility, and potential for additional actions or retaliatory measures related to trade policy.
  • The North America ERP implementation continued to affect planning, production flow, and order fulfillment, with expected productivity gains taking longer to realize.
  • Potential for financial difficulties if the United States or other global economies experience a prolonged economic downturn, as product sales are sensitive to capital spending.
  • Changes in foreign currency may adversely impact net sales, earnings, and financial condition.
  • The company is a defendant in an intellectual property litigation matter with Oxygenator Water Technologies, Inc., with an accrued liability of approximately $20.5 million as of December 31, 2025.

Future Outlook

The company expects to continue operating in a dynamic macroeconomic environment with elevated input costs and global uncertainties. While customer demand remains constructive, particularly for robotic and autonomous solutions, the company anticipates continued margin pressure and lower profitability in the near term due to operational inefficiencies and macroeconomic factors. Management is focused on optimizing the ERP platform, improving execution, and accelerating productivity gains, while selectively investing in strategic growth initiatives.

Management Comments

  • "The North America ERP platform continued to affect operational efficiency during the second quarter, as targeted productivity gains and cost efficiencies have taken longer to realize than expected."
  • "Management remains focused on optimizing the platform, improving execution and fulfillment, and accelerating realization of the expected productivity and operating leverage benefits."
  • "While fiscal year 2026 remains a transition period, we believe the fundamentals of the business remain sound."
  • "The Company continues to invest selectively in strategic growth initiatives, including robotic and autonomous cleaning solutions, while maintaining a disciplined approach to spending, liquidity, working capital, and capital allocation."

Industry Context

StockSavvy.ai notes that Tennant Company's performance reflects broader industry challenges including supply chain disruptions, inflationary pressures, and the ongoing integration of new technologies like robotics and autonomous systems. Competitors may face similar headwinds, but Tennant's specific issues with its ERP implementation appear to be a significant internal factor impacting its results.

Legal Proceedings

  • The Company is a defendant in an intellectual property litigation matter with Oxygenator Water Technologies, Inc. (OWT) in the United States District Court for the District of Minnesota. A jury verdict was returned against the Company in November 2024, and post-trial damages were enhanced in September 2025. As of December 31, 2025, a total accrued liability of approximately $20.5 million was recorded. Both parties have appealed certain aspects of the Court's decisions. A supersedeas bond of $20.3 million has been obtained to stay execution of the judgment pending appeal.

Stakeholder Impact

  • Shareholders: Reduced net income and EPS may negatively impact shareholder returns and stock price.
  • Employees: Restructuring actions and ERP implementation challenges could create uncertainty.
  • Customers: Production and fulfillment constraints may lead to longer lead times or impact order fulfillment.
  • Suppliers: Continued focus on supply chain and material costs may influence supplier relationships.

Next Steps

  • Continue to monitor global macroeconomic environment, including geopolitical conflict, supply chain constraints, and changes in demand.
  • Continue to implement cost management and productivity initiatives.
  • Focus on optimizing the North America ERP platform and improving execution and fulfillment.
  • Continue to invest selectively in strategic growth initiatives, including robotic and autonomous cleaning solutions.
  • Evaluate mitigation strategies for tariffs, including sourcing, supply chain, pricing, and commercial actions.

Key Dates

DateDescription
2024-08-07Entry into the Amended and Restated Credit Agreement (2024 Credit Agreement).
2025-09-01Acquisition of Reinigungstechnik 4 You GmbH (R4Y).
2025-12-09Company concluded it had ability to exercise significant influence over Brain Corp and adopted equity method of accounting.
2026-02-02Acquisition of Clean Machine Falkenberg AB and Repax AB (Clean Machine).
2026-06-30End of the second fiscal quarter for the reported period.
2026-07-28Amendment and extension of four existing EUR-USD cross-currency interest rate swap agreements.
2026-08-06Filing date of the Form 10-Q report.

Recommendation

sell

The significant decline in net income and EPS, coupled with deteriorating gross margins and negative operating cash flow, despite modest revenue growth, indicates worsening financial performance. The ongoing ERP implementation issues and persistent macroeconomic headwinds suggest continued challenges ahead, making the stock a sell at this time.

Keywords

cleaning solutions, floor maintenance, equipment, parts and consumables, service, robotics, autonomous cleaning, ERP implementation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.